Phase 3

Exp Date


Amp Volatility Score


Catalyst Info & Data Links


  • COPD is a chronic progressive disease caused by chronic inflammation and destruction of the airways and lung tissue. While COPD is primarily a respiratory disease, the chronic exposure to toxins in tobacco smoke and resulting lack of oxygen may cause changes in the pulmonary circulation, resulting in chronic pulmonary vasoconstriction and pulmonary hypertension.

  • See more info here

Updated by MV

#COPD #BLPH #Inopulse #Lungdisease

Prior Data (click to view full image)


Trial Design / Revenue (click to view full image)


Recent Posts

See What The Community Is Saying - Click To See Full Post

BLPH - Bellerophon Therapeutic...

#BLPH "announced that the independent Data Monitoring Committee (DMC) has completed its pre-specified interim analysis from the first 100 patients randomized in the Phase 3 COViNOX study of INOpulse® ...

BLPH - Phase 2/3 Publication o...

It will be interesting to see more details of BLPH COViNOX (inhaled nitric oxide) Phase 2 COVID data published in the journal CHEST, we believe tomorrow August 1, 2020. See more details about COViNO...

*Disclaimer: Information provided on and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon